Management of Chronic Pain in the Aftermath of the Opioid Backlash

JAMA. 2017 Jun 20;317(23):2365-2366. doi: 10.1001/jama.2017.4884.

Authors

Kurt Kroenke¹, Andrea Cheville²

Affiliations

¹ VA Health Services Research and Development Service Center for Health Information and Communication, Indiana University School of Medicine, and Regenstrief Institute Inc, Indianapolis.
² Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, Minnesota.

PMID: 28494058
DOI: 10.1001/jama.2017.4884

No abstract available

MeSH terms

Analgesics, Opioid / adverse effects
Analgesics, Opioid / therapeutic use*
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Chronic Pain / epidemiology
Chronic Pain / therapy*
Cognitive Behavioral Therapy
Humans
Medical Marijuana / therapeutic use
Opioid-Related Disorders / etiology*
Placebo Effect
United States / epidemiology

Substances

Analgesics, Opioid
Anti-Inflammatory Agents, Non-Steroidal
Medical Marijuana